A month has gone by since the last earnings report for Ultragenyx (RARE). Shares have lost about 31.1% in that time frame, underperforming the S&P 500.
It has been about a month since the last earnings report for Huntington Ingalls (HII). Shares have lost about 28.7% in that time frame, underperforming the S&P 500.
It has been about a month since the last earnings report for Blueprint Medicines (BPMC). Shares have lost about 21.6% in that time frame, underperforming the S&P 500.
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative
The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
The following are today's upgrades for Validea's Book/Market Investor model based on the published strategy of Joseph Piotroski. This value-quant strategy screens for high book-to-market stocks, and then separates out financially sound firms by looking at a host of improving f
The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.
Lowe's (NYSE: LOW) is one of the biggest retailers in the United States, and it's still outdone by its even larger rival, Home Depot. However, there seems to be plenty of business to go around, and Lowe's is working on taking more of it.
Oil prices took a historic nosedive earlier this week, enduring their deepest plunge since 1991. That sell-off pushed the price of crude down into the low $30s, a roughly 50% haircut from where oil started the year.
Twitter (NYSE: TWTR), Elliott Management, and Silver Lake have come to a deal that keeps chief executive Jack Dorsey at the helm. But with Elliott Management and Silver Lake each getting a seat on the board and with Twitter needing to meet high thresholds, Dorsey's days appear t
Nucor Corp. (NYSE: NUE) stock is currently trading at a five-year low. In fact, the shares are very near a 10-year low as well. At this point, they are down around 50% from the highs reached in early 2018. That's a painful decline, to be sure, but the bigger question now is whet
The outbreak of the COVID-19 illness caused by the SARS-CoV-2 coronavirus continues to march across the globe. There are currently nearly 148,000 confirmed cases and about 5,500 documented fatalities, and communities around the world are taking proactive measures to stem the tid
Almost eight in 10 parents still provide some type of financial support to their adult children, according to a study by Merrill. This includes more than half of all parents who still pay their children's phone bills after their kids reach adulthood.
Jack Daniel's is the largest American whiskey brand in the world and the fourth-biggest spirits brand, but its owner Brown-Forman (NYSE: BF.A)(NYSE: BF.B) is leaving profits on the table.
Year to date, shares of Tilray (NASDAQ: TLRY) are down by 62%, and the company's stock price is now at an all-time low. And while the entire stock market has been dragged down by fears surrounding the COVID-19 outbreak, Tilray's most recent quarterly update didn't help, either.